These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 34917152)
21. State of the Art of Cardiac Amyloidosis. Belfeki N; Ghriss N; Monchi M; Moini C Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189662 [TBL] [Abstract][Full Text] [Related]
22. Cardiac amyloidosis: Recent advances in the diagnosis and therapy. Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995 [TBL] [Abstract][Full Text] [Related]
23. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. Yamamoto H; Yokochi T ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132 [TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis. Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933 [TBL] [Abstract][Full Text] [Related]
25. Accelerated junctional rhythm (AJR) revealing light-chain cardiac amyloidosis: A case report with literature review. Faraj R; Bourouhou Z; Oussama S; Bouamoud A; Rami H; Samih A; Fellat I; Zarzur J; Cherti M Ann Med Surg (Lond); 2022 Mar; 75():103410. PubMed ID: 35386774 [TBL] [Abstract][Full Text] [Related]
26. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist. Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710 [TBL] [Abstract][Full Text] [Related]
27. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Galant NJ; Westermark P; Higaki JN; Chakrabartty A Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611 [TBL] [Abstract][Full Text] [Related]
28. Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease. Zhang KW; Vallabhaneni S; Alvarez-Cardona JA; Krone RJ; Mitchell JD; Lenihan DJ Am J Med; 2021 May; 134(5):587-595. PubMed ID: 33444590 [TBL] [Abstract][Full Text] [Related]
29. A new therapy for transthyretin amyloidosis, no longer an orphan condition. Quarta CC; Tinuper AL; Milandri A; Gagliardi C; Caponeti G; Rapezzi C Eur Heart J Suppl; 2020 Jun; 22(Suppl E):E125-E131. PubMed ID: 32523456 [TBL] [Abstract][Full Text] [Related]
31. From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis. Sabbour H; Hasan KY; Al Badarin F; Alibazoglu H; Rivard AL; Romany I; Perlini S Front Cardiovasc Med; 2021; 8():644508. PubMed ID: 34262948 [TBL] [Abstract][Full Text] [Related]
32. Refractory Heart Failure of Unknown Etiology May Be Cardiac Amyloid If Preceded by Hereditary Neurological Symptoms. Mene-Afejuku T; Akinlonu AA; Graham AN; Akinboboye O Cureus; 2020 Jul; 12(7):e9392. PubMed ID: 32850258 [TBL] [Abstract][Full Text] [Related]
33. Management of Cardiac Amyloidosis: Do's and Don'ts. Alexander KM; Witteles RM Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795 [TBL] [Abstract][Full Text] [Related]
34. A Straining Heart: Transthyretin Amyloidosis as a Cause of Heart Failure. Tender-Vieira J; Pinto C; Matias P; Marques P; Almeida JS Cureus; 2023 Dec; 15(12):e50957. PubMed ID: 38249187 [TBL] [Abstract][Full Text] [Related]